| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02492802 | Mycoses | Drug: posaconazole | University Medical Center Groningen | | 2015-08-01 | 2016-11-17 |
| NCT00811642 | Fungal Infection | Drug: Posaconazole | Merck Sharp & Dohme Corp. | Phase 3 | 2008-11-01 | 2015-06-04 |
| NCT02358499 | Fungal Infections | Drug: Posaconazole | Children's Mercy Hospital Kansas City | Phase 1 | 2015-01-01 | 2016-01-26 |
| NCT00799071 | Chronic Granulomatous Disease | Drug: posaconazole (PSZ) | Radboud University | Phase 2 | 2009-02-01 | 2012-05-30 |
| NCT02968134 | Systemic Fungal Infections | Drug: Posaconazole | Royal Brisbane and Women's Hospital|The University of Queensland | Phase 4 | 2016-11-01 | 2016-11-16 |
| NCT02020213 | Clinical Infection | Drug: Posaconazole | Taichung Veterans General Hospital|Merck Sharp & Dohme Corp. | Phase 4 | 2013-12-01 | 2014-12-11 |
| NCT02372357 | Hematological Malignancy | Drug: Posaconazole prophylaxis 120 mg/m tid|Procedure: Blood sampling | Universitaire Ziekenhuizen Leuven|Institutul Clinic Fundeni Bucharest | Phase 4 | 2012-02-01 | 2015-03-02 |
| NCT00936117 | Leukemia|Fungal Infection | Drug: Posaconazole | M.D. Anderson Cancer Center|Schering-Plough | Phase 2 | 2009-09-01 | 2015-08-24 |
| NCT00550732 | Mycoses | Drug: Posaconazole | Merck Sharp & Dohme Corp.|JSS Medical Research Inc. | Phase 2 | 2007-12-01 | 2015-08-04 |
| NCT00817765 | HIV Infection|Fungal Infection | Drug: Posaconazole|Drug: Fosamprenavir|Drug: Ritonavir | Radboud University|GlaxoSmithKline | Phase 1 | 2009-01-01 | 2009-11-27 |
| NCT02805946 | Allogeneic Stem Cell Transplant|Acute Graft Versus Host Disease|Acute Myeloid Leucaemia|Myelo Dysplastic Syndrome | Drug: posaconazole | Radboud University|Universitaire Ziekenhuizen Leuven | Phase 4 | 2016-08-01 | 2016-06-15 |
| NCT01200355 | Acute Myelogenous Leukemia|Myelodysplastic Syndrome | Drug: micafungin|Drug: posaconazole | Memorial Sloan Kettering Cancer Center|Astellas Pharma US, Inc. | Phase 4 | 2010-09-01 | 2016-04-25 |
| NCT01667107 | Fungal Infection | Drug: Posaconazole|Drug: Calogen庐 | Merck Sharp & Dohme Corp. | Phase 4 | 2013-01-01 | 2014-12-22 |
| NCT00726609 | Mycoses | Drug: Posaconazole | Merck Sharp & Dohme Corp. | | 2006-01-01 | 2015-02-16 |
| NCT01419678 | Lung Transplant Infection|Fungal Infection | Other: collection of blood samples for PK testing | University of Pittsburgh|Merck Sharp & Dohme Corp. | | 2011-10-01 | 2014-12-05 |
| NCT01777763 | Fungal Infections | Drug: Posaconazole 200 mg|Drug: Posaconazole 300 mg | Merck Sharp & Dohme Corp. | Phase 1 | 2009-06-01 | 2016-01-25 |
| NCT00177749 | Fungal Infection | Drug: Posaconazole | University of Pittsburgh|Schering-Plough | Phase 4 | 2004-08-01 | 2008-12-16 |
| NCT02387983 | Fungal Infection | Drug: Posaconazole | Merck Sharp & Dohme Corp. | Phase 1 | 2015-05-01 | 2016-05-26 |
| NCT00750737 | Invasive Fungal Infections|Hematologic Malignancies | Drug: Posaconazole|Drug: ABLC | M.D. Anderson Cancer Center|Enzon Pharmaceuticals, Inc. | Phase 3 | 2008-06-01 | 2016-08-22 |
| NCT00686543 | Fungal Infection|Acute Myelogenous Leukemia|Neutropenia | Drug: Posaconazole | Merck Sharp & Dohme Corp. | Phase 4 | 2007-12-01 | 2015-10-08 |
